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1. Introduction 
Catechol-O-methyltransferase is one of the two 
major enzymes that catalyse the metabolism of 
catecholamines [ 11. In vivo, U-methylation occurs 
exclusively at the me&-position. The enzyme is found 
in high concentration i  liver, kidney and brain, and 
it is also present in spleen, muscle, testes, red cells 
and heart. Because of this wide distribution and the 
relatively poor ph~acolo~c~ activity of the 
me~oxy~atechol~~es, it is generally believed that 
the O-methylation process is one of the most active 
systems for the biological inactivation of catechol- 
amine neurotransmitters. 
We report here that the meta O-methylated cate- 
cholamine derivatives are able to inhibit the acetyl- 
cholinesterase from human erythrocytes and rat brain 
in a reversible and non-competitive manner. The KoaJ 
values ranged from 0.08 mM for (~)normetanephrine 
to 0.56 mM for 3-methoxy dopamine. 
We first observed this phenomenon during the 
course of experiments designed to test the molecular 
speci8city of catecholamine analogues on the regu- 
latory behaviour of rat erythrocyte membrane-bound 
acetylcholinesterase . We have shown that (-)epineph- 
rine changed the co-operativity of the system, with- 
out affecting the specific activity of the enzyme (in 
the absence of allosteric effector) [2]. 
2.1. Emyme ~r~~~at~~~~ 
Human blood was centrifuged 10 min at 3000 
rev./mm The plasma nd the intermediate layer of 
white cells were discarded. The erythrocytes were 
Ebevier/North-Holland Biomedical &eSS 
washed twice with several volumes of solution con- 
taining 155 mM NaC12 mM sodium phosphate 
(buffer pH 7.4) and 10 mM glucose; finally, they were 
adjusted to the original hematocrit n plasma pre- 
inactivated for 30 min at 56-60°C, containing 
10 mM glucose. The red cell suspension was stored at 
4’C and used within 5 days. 
For the determination of acetylchol~esterase 
activity, the membr~es were prepared as in ]3] while 
for ATPase activity, the above membrane prepara- 
tions were further washed twice with imidazole-HCl 
buffer 20 mM, cysteine 1 mM (pH 7.9, and stored in 
the same buffer in liquid nitrogen. For the determina- 
tion of glyceraldehyde 3-phosphate dehydrogenase 
the ghosts were prepared as in [4]. Synaptosomes 
were prepared from rat brain as in [5]. Erythrocyte 
membrane acetylcholinesterase was solubilized with 
0.32% Triton X-100 as in [6]. 
2.2. Enzyme assays 
Acetylcho~estera~ activity was measured as in 
[7]. The standard incubation mixture (2 ml) con- 
tamed isotonic sodium phosphate buffer solution 
(pH 8.0), 0.7 mM acetylthiocholine iodide, 0.5 mM 
5,5’dithio bi+2(nitrobenzoic acid). The reaction was 
initiated by addition of erythrocyte, or synaptosome 
suspension. The aA4r2 was determined for 3 mm 
every 30 s under initial velocity conditions. 
The measurement of ATPase activities were per- 
formed as in f6]. Glyceraldehyde 3.phosphate dehy- 
drogenase was assayed by a procedure recommended 
by Sigma. 
2.3. Others 
(*:)Paranephrine, (~~o~~anep~ne were donated 
by Sterling-Winthrop Research Institute, and other 
catecholamines were purchased from Sigma St Louis. 
37 
Volume 121, number 1 FEBS LETTERS 
Table 1 
November 1980 
The effect of catecholamines analogues on acetylcholinesterase activity (% inhibition) 
Compound (0.35 mM) 4 3 P OL R Whole Brain 
red cells synaptosomes 
1 (-)Epinephrine OH OH OH 
2 (+)Metanephrine OH OCH, OH 
3 (i)Paranephrine OCH, OH OH 
4 (+)Synephrine OH H OH 
5 (-)Neosynephrine H OH OH 
6 (-)Norepinephrine OH OH OH 
7 (i)Normetanephrine OH OCH, OH 
8 (*)Norparanephrine OCH, OH OH 
9 Dopamine OH OH H 
10 3-Methoxydopamine OH OCH, H 
11 (-)Isoproterenol OH OH OH H 
12 L+3,4Dihydroxy- 
phenylalanine 
13 L4-Hydroxy-3-methoxy- 
phenylalanine 
OH OH 
OH OCH, 
4 
4A!H-CH-NH 
I I 
a R 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
x 
COOH 
COOH 
4 / \ 
Q- 
k-C-COW 
- 
3 
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3 X Z 
CH, 
CH, 
CH, 
CH, 
CH, 
H 
H 
H 
H 
H 
/ 
CH, 
CH 
\ 
CH, 
H 
H 
0 0 
52 55 
0 0 
0 0 
0 0 
0 0 
80 76 
0 0 
0 0 
49 51 
0 0 
0 15 
0 0 
14 4-Hydroxy-3 methoxy- 
phenylpiruvic acid 
15 4-Hydroxy 3-methoxy- 
phenyllactic acid 
OH OCH, H =o 0 0 
OH OCH, H OH,H 0 0 
4 3 Y 
16 D,L-3,4 Dihydroxy- 
mandelic acid OH OH OH 0 0 
17 D,L4 Hydroxyd metboxy- 
mandelic acid OH OCH, OH 0 0 
18 3,4-Dihydroxyphenyl- 
acetic acid OH OH H 0 0 
19 4-Hydroxy-3 methoxy- 
phenylacetic acid OH OCH, H 0 0 
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3. Results and discussion Table 2 
Values of I&:,, (mM) for acetylcholinesterase 
3.1. Acetylcholinesterase from erythrocyte 
Table 1 summarizes the actions of catecholamine 
analogues (0.35 mM) on the activity of acetylcholin- 
esterase from human whole red cells. (-)Epinephrine, 
(-)norepinephrine and dopamine (rows 1,6 and 9) 
did not inhibit the enzyme whereas those compounds 
with a methoxy+oup in position 3 were active 
(rows 2,7 and 10). (~)Par~eph~ne and (&)norpara- 
nephrine with the methoxy-group in position 4 had 
no effect (rows 3 and 8). Inhibitor activity did not 
appear to be influenced by the hydroxyl group on 
the &carbon (see 3-methoxy dopamine row 10). The 
presence of a carboxyl group on the a-carbon inhib- 
ited the action of a 3-methoxy catecholamine deriva- 
tive (row 13). Catecholamines with a methoxygroup 
in position 3, but lacking amino function, were inac- 
tive (rows 14,15, I7 and 19). 
Compound Erythrocyte Brain 
membrane synaptosomes 
(+)Normetanephtine 0.08 0.09 
(*)Metanephrine 0.40 0.56 
3-Methoxy dopamine 0.50 0.60 
The values of h and KQJ were determined graphically using 
the equation: 
Log (Yl(V, - VI) = Log K - h log I 
since the inhibition by 3 methoxy derivatives approached 
100%; Vo, reaction rate in absence of effector; Y, reaction 
rate in the presence of a inhibitor concentration; K, 5, con- 
centration that produces 50% inhibition of the reaciion rate; 
A value of h = 1 was obtained for all the different inhibitors 
Similar esults to those presented in table 1 were 
obtained with acetylcholinesterase from erythrocyte 
membrane or Triton X-l 00 membrane soluble prepa- 
ration. 
Normetanephrine-i~ibited acetylcholinesterase 
from human membrane rythrocyte in a simple non- 
competitive manner (not illustrated). The inhibition 
is reversible after removing the inhibitor by washing 
the membrane-bound enzyme. Preincubation with 
the inhibitors did not produce any more inhibition 
than that observed when each inhibitor was added 
just prior to the assay. The concentration of inhibi- 
tors required to produce 50% inhibition is shown in 
table 2. The KO,,-values ranged from 0.08 mM for 
~*)normethaneph~ne to 0.50 mM for 3-methoxy 
dopamine. These Ko,-values were not modified by 
the simultaneous presence of catecholamines 
(1.4 mM) lacking inhibitory activity such as (-)epi- 
nephrine, (-)norepinephrine and (-)isoproterenol. 
Pyridine 2-aldoxime methiodide (PAM) which inhib- 
its acetylcholinesterase by interacting with its active 
site did not change the values of Ko5 for meta 
U-methyl catecholamines. 
3.3. Acetylcholinesterase from brain synaptosomes 
Acetylcholinesterase i  present in acetylcholine 
&d catecholamine urons [I] and is associated with 
the interactions between chohner~c and mono- 
aminergic systems [8,9]. Table 1 shows that the 
meta ~-methylcatecholam~es also inhibit the acetyl- 
cholinesterase from synaptosomes isolated from rat 
brain homogenates. The &s-values for each inhibitor 
are similar to those shown for erythrocyte nzymes 
(table 2). 
3.4. PhysiologikaI sipnificance 
3 2. Other enzymes fern membrmte e?ythrocytes 
The enzymatic activities of the erythrocyte 
membrane-bound enzymes (Na’ t K*)ATPase, 
(Mgl+)ATPase and glyceraldehyde 3-phosphate 
dehydrogenase w re unaffected by the presence of 
0.5 mM meta O-methylcatecholamines. 
The concentrations of the methoxycatecholamines 
able to inhibit the acetylcholinesterase (table 2) 
exceed those that could be expected to occur in vivo. 
Thus, the phy~olo~cal rel&ance of the observations 
presented here is questionable. However, the selectiv- 
ity for the 3.methoxy catecholamine s rviatives 
action shown in table 1 is of interest, and one is 
tempted to point out the importance of the changes 
in the acetylcholinesterase ctivity by 3-methoxy 
neurotransmitter derivatives in the process of neuro- 
nal function. This idea is attractive because in 
Parkinsonism, for example, the loss of dopamine 
alters the cholinergic-dopaminergic balance, and an 
anticholinergic drug is of benefit along with Ldopa 
(precursor of dop~ine) in the treatment of the 
disease [lo]. Thus, the pos~b~ity exists that the 
above balance is related to the i~ibitory action of 
meta O-methyl catecholamine derivative on the 
acetylcholinesterase ctivity. 
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